DOI QR코드

DOI QR Code

Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma

  • Arwa Ashoor (Department of Breast Surgery, Sandwell and West Birmingham NHS Trust, City Hospital Birmingham) ;
  • Julie Shephard (Department of Breast Radiology, Sandwell and West Birmingham NHS Trust, City Hospital Birmingham) ;
  • Germana Lissidini (Division of Breast Surgery, European Institute of Oncology, IRCCS) ;
  • Luca Nicosia (Division of Breast Radiology, European Institute of Oncology, IRCCS)
  • Received : 2022.03.27
  • Accepted : 2022.03.28
  • Published : 2022.07.01

Abstract

Keywords

References

  1. Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN, et al. Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: radiology scientific expert panel. Radiology 2021;300:E323-E327  https://doi.org/10.1148/radiol.2021210436
  2. El-Sayed MS, Wechie GN, Low CS, Adesanya O, Rao N, Leung VJ. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT. Clin Med (Lond) 2021;21:e633-e638  https://doi.org/10.7861/clinmed.2021-0420
  3. Weeks JK, O'Brien SR, Rosenspire KC, Dubroff JG, Pantel AR. Evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clin Nucl Med 2021;46:1011-1012  https://doi.org/10.1097/RLU.0000000000003711
  4. Centers for Disease Control and Prevention. The Moderna COVID-19 vaccine's local reactions, systemic reactions, adverse events, and serious adverse events. CDC.gov Web site. https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html. Accessed February 10, 2021 
  5. CDC. Systemic reactions. CDC.gov Web site. https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html#:~:text=For%20both%20age%20groups%2C%20fatigue,the%20older%20group%20(10.9%25). Accessed February 10, 2021 
  6. RCR. Guidance on screening and symptomatic breast imaging, fourth edition. RCR.ac.uk Web site. https://www.rcr.ac.uk/publication/guidance-screening-and-symptomatic-breast-imaging-fourth-edition. Accessed March 23, 2021 
  7. Grimm L, Destounis S, Dogan B, Nicholson B, Dontchos B, Sonnenblick E, et al. SBI recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination. sbi-online.org Web site. https://www.sbi-online.org/Portals/0/Position%20Statements/2021/SBI-recommendations-for-managing-axillary-adenopathy-post-COVID-vaccination.pdf. Accessed March 23, 2021 
  8. Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean J Radiol 2021;22:1938-1945 https://doi.org/10.3348/kjr.2021.0350